Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Post by djbon Dec 19, 2012 12:02pm

300 Views

Post# 20750892

Value in the tax loss carry forward

By my calculations Allon has to date $49 million CAD and $20 million USA in tax loss carry forward which is an asset to a larger company that needs to offset income.

If I was a larger pharmaceutical company I could buy Allon at $0.03/share or $4.3 million and enjoy $65 million in income tax savings.

And there is some money left in the bank.

Bullboard Posts

This battery metals stock is on a path to the global stage